Clinical trial

A Study to Examine the Effect of Particle Size on Bioequivalence and Bioavailability

NCT00517543

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-08-01

PhasePHASE1

Study timeline

Study start (unknown)2007-08-01Date precision: month

Registry last updated2010-10-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Obstructive Pulmonary Disease (COPD)unresolved

Rheumatoid Arthritisunresolved

Atherosclerosisunresolved

Interventions

GW856553DRUG

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

TacomaWashington, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00517543 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.